Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shuai Ren
Institutions:
Nanjing University of Chinese Medicine,
Binzhou Medical University,
Central Hospital of Zibo
Observed institutions:
Nanjing University of Chinese Medicine,
Binzhou Medical University,
Central Hospital of Zibo
ORCID:
0000-0003-4902-6298
Observed ORCID:
0000-0003-4902-6298
OpenAlex ID:
A5121497200
Engineered neutrophil membrane nanosystem for targeted siRNA therapy in myocardial ischemia–reperfusion injury
2025
·
Yaohui Jiang
, Zhe Wang
, et al.
·
Journal of Nanobiotechnology
·
13
Trends in Gallbladder and Biliary Tract Cancer Global Burden (1990–2021): A Socioeconomic Gradient Analysis and Projections for 2040
2026
·
Yimao Wu
, Guanyu Yang
, et al.
·
BIO Integration
·
8
PDF
Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy
2026
·
Maojin Tian
, Xiangwei Meng
, et al.
·
Materials Today Bio
·
3
Precision nanomedicine in cardiovascular disease: Engineered siRNA delivery platforms for atherosclerosis and ischemic heart disease
2026
·
He Lu
, Qi Huang
, et al.
·
Chemical Engineering Journal
·
2
Qian Yang Yu Yin Granule ameliorates hypertension-induced renal injury through the modulation of oxidative stress via Sestrin2 signaling pathway
2026
·
Lichao Qian
, Shuang Shen
, et al.
·
Journal of Pharmacy and Pharmacology
·
1
Comment on “A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study”
2026
·
Jiaqi Liang
, Shuai Ren
, et al.
·
British Journal of Cancer
Show more works
View as search
Works count:
6
Citation count:
27
H-index:
3
I10-index:
1
Year
Topic
Type